Inhibitors of Mitogen-Activated Protein Kinase-Activated Protein Kinase 2 (MK2) as Treatment for Inflammatory Diseases.
Journal
ACS medicinal chemistry letters
ISSN: 1948-5875
Titre abrégé: ACS Med Chem Lett
Pays: United States
ID NLM: 101521073
Informations de publication
Date de publication:
12 Sep 2024
12 Sep 2024
Historique:
received:
06
08
2024
pmc-release:
12
09
2025
medline:
18
9
2024
pubmed:
18
9
2024
entrez:
18
9
2024
Statut:
epublish
Résumé
The invention in this patent application relates to 9,10,11,12-tetrahydro-8
Identifiants
pubmed: 39291023
doi: 10.1021/acsmedchemlett.4c00393
pmc: PMC11403732
doi:
Types de publication
Editorial
Langues
eng
Pagination
1421-1423Informations de copyright
Published 2024 by American Chemical Society.
Déclaration de conflit d'intérêts
The author declares no competing financial interest.